Navigation Links
LMA Fastrach™ (Reusable)

ProductsLMA Fastrach™ (Reusable)
Company Vitaid
Item LMA Fastrach™ (Reusable)
Features 
  • Developed for the anticipated and unexpected difficult airway
  • Ideal for emergency carts and ambulances
  • Designed for rapid, blind intubation
  • Proven use in difficult to intubate patients
  • Ventilation possible between intubation attempts
  • Dedicated low volume, low pressure ET tube
  • One handed insertion without moving the head or neck from neutral position
  • Available in both reusable and single use versions
  • Latex free
  • Description The Intubating LMA™ Airway.

    Developed for cardiopulmonary resuscitation and the anticipated or unexpected difficult airway, the LMA Fastrach™ has been designed to facilitate blind intubation without moving the head or neck. The LMA Fastrach™ allows continuous ventilation between intubation attempts.

    Selected by emergency teams worldwide including NASA for its ease and speed of use, included in the Difficult Airway Algorithms of the AHA and ASA, the LMA Fastrach™ has contributed to saving thousands of lives.
    Info Vitaid
    Customer Service: (800) 267-9301
    Web site: http://www.vitaid.com

    Related medicine products :

    1. LMA Fastrach™ (Single Use)
    2. LMA Flexible™ (Reusable)
    3. LMA Classic™ (Reusable)
    ... No need to add individual components ... range of trauma indications. Made of an ... than conventional fixators, only much lighter. This ... apply, and more comfortable for the patient. ...
    ... an X-ray contrast medium for ... for: angiography, urography, phlebography and ... of the basal cisterns, following ... cholangio (pancreato) graphy (ERC(P)), herniography, ...
    ... (gadobenate dimeglumine) is a paramagnetic MRI contrast ... with gadobenate, a chelating agent that forms ... godolinium ion. It is salified with meglumine ... with all the physico-chemical features typical of ...
    ... ferumoxides) is Advanced Magnetics' contrast agent for use ... It is the first organ-specific MRI contrast agent ... function, the agent is taken up by macrophages ... in most tumors. The liver is a principal ...
    Medicine Products:
    (Date:7/30/2015)... FL (PRWEB) , ... July 30, 2015 , ... ... Florida’s (UCF) College of Medicine as Assistant Professor of Plastic Surgery. This is ... Dr. Clevens has worked closely with the university, developing a strong presence and a ...
    (Date:7/30/2015)... ... July 30, 2015 , ... ... the latest issue of Inclusive™ magazine, its multimedia publication focused on implant dentistry, ... of the new issue, Volume 6, Issue 2, as well as past issues ...
    (Date:7/30/2015)... ... July 30, 2015 , ... Boston Web Marketing ... Summit. Google Partners is the platform for search marketing agencies to communicate with ... tools necessary to run successful search marketing campaigns. Google Partners also affords businesses ...
    (Date:7/30/2015)... ... July 30, 2015 , ... Quintessa Medical Spa is happy ... nonsurgical treatment designed specifically for the elimination of excess tissue under the ... locations in the state of Wisconsin to offer this innovative treatment. , Developed by ...
    (Date:7/30/2015)... ... 30, 2015 , ... The American Association of Poison Control ... the reinstitution of National Prescription Drug Take-Back Days. The 10th event of this ... 2:00 PM local time. On the 26th, the DEA, with the assistance of ...
    Breaking Medicine News(10 mins):Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 3Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 2Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 3Health News:Glidewell Laboratories Puts Out Latest Issue of Dental Implant Magazine Inclusive™ 4Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:Quintessa MedSpa Offers Nonsurgical Double-chin Elimination 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 3
    ... ... them , ... 2010 -- Still hunting for the perfect Mother,s Day gift idea? While it,s wonderful to ... universally don,t have enough of is sleep. With Mother,s Day right around the corner on May ...
    ... ... Assess & Treat the Country’s Pest Management Needs, , ... (PRWEB) April 29, 2010 -- Most people are aware of the ... January 12th. While the country is still dealing with widespread damage to its infrastructure ...
    ... Geneva, 29 April 2010 -- Lung cancer patients whose tumors ... than those who do not, Canadian researchers have found. Their ... Geneva, highlights the exciting possibility that the molecule could soon ... is a receptor that is found on the surface of ...
    ... Practicing non-pharmaceutical interventions (NPIs) such as hand-washing and ... pandemic flu, but more research on these measures is ... May issue of AJIC : American Journal ... Association for Professionals in Infection Control and Epidemiology, Inc. ...
    ... ... errors and boost quality of service , ... Trevose, PA (PRWEB) April 29, 2010 -- Airclic, ... logistics and field service operations, today introduced Clinical Perform, a SaaS-based mobile software product ...
    ... clumps of protein, not plaques, may cause the disease, ... research could change the way scientists view the causes -- ... A study published online this month in the Annals ... (abeta) proteins called oligomers could be a prime cause of ...
    Cached Medicine News:Health News:The Perfect Mother's Day Gift Idea: A Good Night's Sleep 2Health News:Clark Pest Control Executive Asked to Aid Haitian Government with Post-Earthquake Pest Issue 2Health News:Clark Pest Control Executive Asked to Aid Haitian Government with Post-Earthquake Pest Issue 3Health News:CXCR4: A new drug target in lung cancer 2Health News:Hand-washing, mask-wearing may limit transmission of pandemic flu 2Health News:Hand-washing, mask-wearing may limit transmission of pandemic flu 3Health News:Airclic Introduces Clinical Perform™ 2Health News:Airclic Introduces Clinical Perform™ 3Health News:New Finding Could Mark Shift in Alzheimer's Research 2Health News:New Finding Could Mark Shift in Alzheimer's Research 3
    (Date:7/30/2015)... N.J. , July 30, 2015 Eisai ... in the United States , European ... FDA, EMA and MHLW, respectively) for eribulin, for the ... who have received prior chemotherapy for advanced or metastatic ... on data from a pivotal global Phase 3 clinical ...
    (Date:7/30/2015)... , July 30, 2015 Takeda Pharmaceutical ... study to fulfill the post-marketing commitment and submissions ... Pan European Multi-Database Bladder Cancer Risk Characterization Study ... cohort study, conducted in four European countries, for ... up to 10 years of follow-up. Findings demonstrate ...
    (Date:7/30/2015)... , July 30, 2015  Big Cloud Analytics, ... analytics technology, announces it is working with Intel ... for the new Lockheed Martin Healthcare Technology Alliance. ... health information technology providers, medical technology companies and ... and innovation to improve care in rapidly evolving ...
    Breaking Medicine Technology:Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 2Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 3Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 6Big Cloud Analytics Develop Internet of Things (IoT) Solutions with Intel Supporting Launch of Lockheed Martin Healthcare Technology Alliance 2Big Cloud Analytics Develop Internet of Things (IoT) Solutions with Intel Supporting Launch of Lockheed Martin Healthcare Technology Alliance 3